Stay updated on Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial

Sign up to get notified when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The Study Details page for NCT03580369 appears unchanged between the two screenshots; no new or removed sections were detected. The content and layout remain consistent with the original version.
    Difference
    0.2%
    Check dated 2025-11-03T21:08:28.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T05:56:51.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added revision label v3.1.0; removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the older revision note v3.0.2.
    Difference
    0.3%
    Check dated 2025-09-29T03:14:14.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed; overall the changes are minor and do not affect core content.
    Difference
    0.1%
    Check dated 2025-09-14T20:20:50.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T17:07:26.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as new publications related to drug safety and clinical trials. Notably, the drug ligelizumab is highlighted, indicating a focus on its efficacy and safety in treating chronic spontaneous urticaria.
    Difference
    19%
    Check dated 2025-08-31T12:13:22.000Z thumbnail image

Stay in the know with updates to Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ligelizumab for CSU Treatment in Adolescents and Adults Clinical Trial page.